![]() |
|
Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis
Masayoshi Harigai, Michi Tsutsumino, Hideto Takada, Kenji Nagasaka
Korean J Intern Med. 2019;34(3):492-503. Published online 2019 Jan 9 DOI: https://doi.org/10.3904/kjim.2018.366
|
|
Citations to this article as recorded by
Granulomatosis With Polyangiitis Presenting With Kidney Failure: A Case Report
Konrad Haraziński, Weronika Goliat, Michalina Goliat-Mazurek, Dominik Mazurek, Izabela Jastrzebska, Anna Kaput, Kamil Poreba , Marcel Bobinski, Alicja Czyszczon, Aneta Tkaczyk
Cureus.2025;[Epub] CrossRef Tocilizumab Attenuates Anti-neutrophil Cytoplasmic Antibody-associated Nephritis Occurring during Abatacept and Adalimumab Therapy for Rheumatoid Arthritis
Yusuke Yoshimura, Shun Watanabe, Masayuki Yamanouchi, Daisuke Ikuma, Hiroki Mizuno, Akinari Sekine, Eiko Hasegawa, Tatsuya Suwabe, Kei Kono, Keiichi Kinowaki, Kenichi Ohashi, Yoshifumi Ubara, Naoki Sawa
Internal Medicine.2023; 62(14): 2099. CrossRef Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis
Masayoshi Harigai, Hideto Takada
Modern Rheumatology.2022; 32(3): 475. CrossRef Current concepts in granulomatosis poly angiitis and the eye
Bala Murugan Sivaraman, Parthopratim Dutta Majumder, Padmamalini Mahendradas, Anjana Somanath, Richa Pyare, Aditya Patil
Current Opinion in Ophthalmology.2022; 33(6): 564. CrossRef Vasculopathy in patients with severe COVID-19 infection
Т. V. Beketova, E. V. Nasonov
Clinical Medicine (Russian Journal).2020; 98(5): 325. CrossRef
|